Influenza and Other Respiratory Viruses

Article	Citations
Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong	200
Changes in Respiratory Syncytial Virus‐Associated Hospitalisations Epidemiology After Nirsevimab Introduction in Lyon, France	77
Potential Arrival Pathway for Highly Pathogenic Avian Influenza H5N1 to Oceania	75
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months	66
Home‐Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021–2022—A Pilot Study	66
Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach	57
Novel and extendable genotyping system for human respiratory syncytial virus based on whole‐genome sequence analysis	54
The association between ambient pollutants and influenza transmissibility: A nationwide study involving 30 provinces in China	53
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures	49
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan	45
Predicting virologically confirmed influenza using school absences in Allegheny County, Pennsylvania, USA during the 2007‐2015 influenza seasons	40
Issue Information	36
	35
Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing	34
Association of Symptoms and Viral Culture Positivity for SARS‐CoV‐2—Tennessee, April–July 2020	33
Issue Information	33
Use of whole genome sequencing to identify low‐frequency mutations in SARS‐CoV‐2 patients treated with remdesivir	32
Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt	31
Low prevalence of seasonal influenza viruses in Hong Kong, 2022	31
	29
Influenza vaccination uptake among at‐risk patients in Switzerland—The potential of national claims data for surveillance	28
Household transmission of SARS‐CoV‐2 during the Omicron wave in Shanghai, China: A case‐ascertained study	28
	27
Using capture‐recapture methods to estimate influenza hospitalization incidence rates	27
	26

Transmissibility of severe acute respiratory syndrome coronavirus 2 among household contacts of coronavirus disease 2019‐positive patients: A community‐based study in India	25
INFINITy: A fast machine learning‐based application for human influenza A and B virus subtyping	24
Predictors of Respiratory Syncytial Virus, Influenza Virus, and Human Metapneumovirus Carriage in Children Under 5 Years With WHO‐Defined Fast‐Breathing Pneumonia in Pakistan	24
Issue Information	23
	23
Issue Information	22
Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012–2022	21
Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review	21
Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers	21
Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia	20
	20
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation	20
Etiologies of outpatient medically attended acute respiratory infections among young Ecuadorian children prior to the start of the 2020 SARS‐CoV‐2 pandemic	19
The role of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in nine tropical Asian countries	19
Antibiotic prescription for outpatients with influenza and subsequent hospitalisation: A cohort study using insurance data	19
Interactions among acute respiratory viruses in Beijing, Chongqing, Guangzhou, and Shanghai, China, 2009–2019	19
Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care	19
	18
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries	18
	18
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network	18
SARS‐CoV‐2 infection rate in Antananarivo frontline health care workers, Madagascar	17
A novel household‐based patient outreach pilot program to boost late‐season influenza vaccination rates during the COVID‐19 pandemic	17
A comparative immune response to COVID‐19 vaccination between children and adults	17
COVID‐19 risk perception and associated factors in older adults in southern Ethiopia	17
Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines	16
Estimated mortality due to seasonal influenza in southeast of Iran, 2006/2007 to 2011/2012 influenza seasons	16
Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada	16
Transmission of Respiratory Syncytial Virus genotypes in Cali, Colombia	15
Susceptibility of different cell lines to the novel canine coronavirus CCoV‐HuPn‐2018	15
An assessment of the current epidemiological and laboratory capacities for influenza‐like illnesses and severe acute respiratory infection surveillance, Yemen 2022	15
Establishing a COVID‐19 pandemic severity assessment surveillance system in Ireland	15
EMARIS Conference 2023: Convergence of science, policy, and practice on acute respiratory infections in post COVID‐19 Eastern Mediterranean Region	15
Spatial‐temporal distribution and sequence diversity of group a human respiratory syncytial viruses in Kenya preceding the emergence of ON1 genotype	15
Acute respiratory infections among individuals seeking outpatient care in the states of Washington and Michigan by pregnancy status, 2011–2016	15
Intranasal antisepsis to reduce influenza virus transmission in an animal model	15
Comparative complete scheme and booster effectiveness of COVID‐19 vaccines in preventing SARS‐CoV‐2 infections with SARS‐CoV‐2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case–case study based on	14
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID‐19 Survivors: A 2‐Year Cohort Study	14
Factors influencing sensitivity of a rapid influenza diagnostic test in a community‐based population of kindergarten through 12th‐grade students: Wisconsin 2015–2020	14
Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic	14
Comparative analysis of COVID‐19 case fatality rate between two waves in Nepal	14
Rapid assessment of case recruitment tools to inform integrated surveillance of influenza and other respiratory viruses in Eastern Mediterranean countries	14
Issue Information	14
Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2	13
Persistence of racial/ethnic and socioeconomic status disparities among non‐institutionalized patients hospitalized with COVID‐19 in Connecticut, July to December 2020	13
Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV‐A genotype ON1 variants	13
The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021	13
Lower cognitive scores among toddlers in birth cohorts with acute respiratory illnesses, fevers, and laboratory‐confirmed influenza	13
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022	13
Evidence of Reverse Zoonotic Transmission of Human Seasonal Influenza A Virus (H1N1, H3N2) Among Cats	13

Issue Information	12
Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022	12
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial	12
Clinical Outcomes of Coronavirus Disease 2019 in People Living With Human Immunodeficiency Virus in South Korea: A Nationwide Population‐Based Cohort Study	12
State and situation of avian influenza in the Eastern Mediterranean Region	12
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study	12
Next‐Generation Sequencing for Characterizing Respiratory Tract Virome and Improving Detection of Viral Pathogens in Children With Pneumonia	12
Avian Influenza Virus (H5N1) Was Not Detected Among Dairy Cattle and Farm Workers in Pakistan	12
No evidence for HPAI H5N1 2.3.4.4b incursion into Australia in 2022	11
Correction to ‘Uptake and Impact of Vaccinating Primary School Children Against Influenza: Experiences in the Fourth Season of the Live Attenuated Influenza Vaccination Programme, England, 2016/2017’	11
Correction to ‘Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain’	11
Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community: A prospective cohort study in Japan	11
Molecular Epidemiology of Human Parainfluenza Virus Type 3 in Children With Acute Respiratory Tract Infection in Hangzhou	11
Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination	11
Behavioral factors associated with SARS‐CoV‐2 infection in Japan	11
Effect of COVID‐19 vaccine on menstrual experience among females in six Arab countries: A cross sectional study	11
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV	11
Issue Information	11
Biases in Routine Influenza Surveillance Indicators Used to Monitor Infection Incidence and Recommendations for Improvement	10
Development of multiplex RT‐ddPCR assays for detection of SARS‐CoV‐2 and other common respiratory virus infections	10
Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022	10
Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study	10
Attitudes, beliefs and practice of Egyptian healthcare workers towards seasonal influenza vaccination	10
COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants	10
Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)	10
Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016–2018	10
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017	10
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults ≥60 years of age	9
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID‐19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial	9
Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season	9
Impact of varying wave periods of COVID‐19 on in‐hospital mortality and length of stay for admission through emergency department: A territory‐wide observational cohort study	9
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post‐discharge assessed by Respiratory Intensity a	9
Shifts in Respiratory Virus Epidemiology on Reunion Island From 2017 to 2023: Impact of COVID‐19 Pandemic and Non‐Pharmaceutical Interventions	9
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults	9
Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic	9
	9
Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 t	9
Avian Influenza Virus Surveillance Across New Zealand and Its Subantarctic Islands Detects H1N9 in Migratory Shorebirds, but Not 2.3.4.4b HPAI H5N1	9
A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom	9
Issue Information	8
COVID‐19 in Morocco's region: Observational study of prevalence in symptomatic adults using the PANBIOS® rapid antigen test September 2021	8
Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019	8
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4	8
Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024	8
Issue Information	8
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic	8
Comparison of the clinical features and outcomes of severe seasonal influenza and COVID‐19 patients in Tunisia between 2021 and 2022	8
Neutrophil CD64 index as a good biomarker for early diagnosis of bacterial infection in pregnant women during the flu season	8
Effect of antipyretics on performance of influenza surveillance in Ghana	8
Methods to account for measured and unmeasured confounders in influenza relative vaccine effectiveness studies: A brief review of the literature	8
Detection of Respiratory Viruses Other Than SARS‐CoV‐2 in a Large Hospital Laboratory in Rome, Italy, During the Seasons 2016–2017 to 2022–2023	8
	8
	8
Letter to editor regarding the systematic review and meta‐analysis by Coleman et al. on the effectiveness of MF59‐adjuvanted seasonal influenza vaccine in older adults	8
The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome	8
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study	8
Comparative Analysis of Influenza Epidemiology Before and After the COVID‐19 Pandemic in Argentina (2018–2019 vs. 2022–2023)	8
	8
Associations Between Severe Influenza‐Complicated Thromboembolism Events, Intensive Care Unit Stays and Mortality, and Associated Risk Factors: A Retrospective Cohort Study	7
Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November	7
	7
Singapore's COVID‐19 Genomic Surveillance Programme: Strategies and Insights From a Pandemic Year	7
Impact of coinfection status and comorbidity on disease severity in adult emergency department patients with influenza B	7
	7
Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment	7
Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16	7
Viral Acute Lower Respiratory Tract Infections (ALRI) in Rural Bangladeshi Children Prior to the COVID‐19 Pandemic	7
In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019	7
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020	7
	7
Change in patterns of hospitalization for influenza during COVID‐19 surges	7
A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh	6
Correction to “Surveillance of seasonal influenza viruses during the COVID‐19 pandemic in Tokyo, Japan, 2018–2023, a single‐center study”TakahashiH, NagamatsuH, YamadaY, et al. Influenza and Other Res	6
Issue Information	6
Risk factors for infection with influenza A(H3N2) virus on a US university campus, October–November 2021	6
Coronary and Cerebrovascular Events and Exacerbation of Existing Conditions After Laboratory‐Confirmed Influenza Infection Among US Veterans: A Self‐Controlled Case Series Study	6
Atypical interseasonal respiratory syncytial virus infection in hospitalized children up to 12 years old	6
	6
The evaluation of an automated mariPOC SARS‐CoV‐2 antigen test compared to RT‐qPCR SARS‐CoV‐2 assay and comparison of its sensitivity in Delta‐ and Omicron‐variant samples	6
Seasonality and Co‐Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness—Valencia Region, Spain, 2010–2021	6

Examining the Influenza A Virus Sialic Acid Binding Preference Predictions of a Sequence‐Based Convolutional Neural Network	6
Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan	6
Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic	6
Time to SARS‐CoV‐2 clearance in African, Caucasian, and Asian ethnic groups	6
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote moni	6
Issue Information	6
Estimating SARS‐CoV‐2 transmission in educational settings: A retrospective cohort study	6
Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK	6
A phased strengthening of laboratory capacity in the Eastern Mediterranean Region during the COVID‐19 pandemic	6
	6
Bidirectional Evolution of SARS‐CoV‐2 Virus in Immunocompromised Hosts	6
Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance	6
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–2015	6
	6